Skip to main content

Newsroom

Latest News

January 31, 2008
WASHINGTON, D.C. – Stemming from mounting Congressional pressure, the Food and Drug Administration (FDA) has decided to reverse its earlier decision of closing up to 13 of its field laboratories, including the Federal Center lab located in Lakewood.
January 29, 2008
DeGette Assails Bush Administration for Barriers to Health Care that Keep the Number of Uninsured American's at 47 Million

WASHINGTON,D.C. – With the number of uninsured American's hovering at 47 million –including almost 10 million children, Energy and Commerce CommitteeVice Chair Diana DeGette (D-CO) today assailed the Bush Administrationfor its failure to tear down barriers to health care.

January 28, 2008

WASHINGTON, D.C. – Energy and Commerce Committee Vice Chair DianaDeGette (D-CO), chief architect of the Stem Cell Research EnhancementAct, today offered the following response to President George W. Bush'sState of the Union address:

"I am glad that President Bush hasrecognized the recent advances in stem cell research. This againhighlights the need for a new, national initiative supporting all typesof ethical cell based research, including embryonic stem cell research.We must establish a robust national stem cell research program with astrict ethical framework.

January 28, 2008

WASHINGTON, D.C. – U.S. Representative Diana DeGette (D-CO) todayreleased the following statement on Private First Class Duncan C.Crookston, who died late last week from complications resulting frominjuries sustained in Iraq:

"Private First Class Duncan C. Crookston served his country with greathonor and distinction. It is a tragedy when someone with such a brightfuture loses their life so young. His service to our country is greatlyappreciated by Coloradoans and Americans nationwide.

January 24, 2008
DeGette Says We Must Focus on Prevention and Disease Management

WASHINGTON, D.C. – Co-Chair of the House Diabetes CaucusCongresswoman Diana DeGette (D-CO) issued the following comments todayon newly released figures from the American Diabetes Association (ADA)showing an increase in economic costs of diabetes in 2007. At anestimated $174 billion annually, costs associated with diabetes haverisen 32% since last evaluated in 2002.

January 23, 2008

WASHINGTON, D.C. – Energy and Commerce Committee Vice Chair DianaDeGette (D-CO) today voted to support the State Children's HealthInsurance Program (SCHIP) and override the President's veto ofbipartisan legislation to provide health care to over 10 millionlow-income children nationwide. Unfortunately, 152 House Republicansvoted lock-step with President Bush to sustain the veto on a vote of260 to 152 blocking nearly 4 million additional low-income childrenfrom receiving health care coverage.

January 22, 2008
Interest Rate Cut Step in Right Direction as Consumers Face Tough Economic Times

WASHINGTON,D.C. – Chief Deputy Whip Diana DeGette (D-C0) today issued thefollowing statement today after the Federal Reserve Board issued anemergency rate cut of a key interest rate by 3/4 of a percentage point:

January 17, 2008

Stem Cell Research Advancement Represents Progress


WASHINGTON, D.C. – With today's announcement of another stem cellresearch advancement, Energy and Commerce Committee Vice Chair DianaDeGette (D-CO), chief architect of the Stem Cell Research Enhancement Act, offered the following statement today:

January 15, 2008
With FDA's Lack of Recall Authority and TracingSystem, Consumers Must Be Confident in Foods Derived from ClonedAnimals in U.S. Market Place

January 10, 2008

WASHINGTON, DC – Energy and Commerce Committee Vice Chair Diana DeGette (D-CO), chief architect of the Stem Cell Research Enhancement Act, released the following statement regarding the news of an additional method of stem cell research:

"I continue to be encouraged by the development of new methods for stem cell research. Because the research announced today destroys about twenty-percent of the embryos used in this technique, it will not solve the ethical concerns raised by those who oppose embryonic stem cell research.